Mesoblast Ltd
NASDAQ:MESO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
NASDAQ:MESO
|
AU |
|
E
|
Ekachai Medical Care PCL
SET:EKH
|
TH |
|
S
|
SP Group A/S
F:1PU2
|
DK |
|
M
|
Mitsubishi Heavy Industries Ltd
F:MIH
|
JP |
|
R
|
Ryder System Inc
DUS:RYD
|
US |
|
C
|
CIMB Group Holdings Bhd
KLSE:CIMB
|
MY |
|
Atlassian Corporation PLC
NASDAQ:TEAM
|
UK |
|
M
|
Melco Resorts & Entertainment Ltd
F:MAS
|
HK |
|
E
|
EDP Energias de Portugal SA
DUS:EDP
|
PT |
|
Virgin Galactic Holdings Inc
F:0QL
|
US |
|
Basic Fit NV
F:B4F
|
NL |
|
Alamtri Resources Indonesia Tbk PT
F:A640
|
ID |
|
Northern Trust Corp
NASDAQ:NTRS
|
US |
|
T
|
Telefonaktiebolaget LM Ericsson
SWB:ERCG
|
SE |
|
ION Acquisition Corp 1 Ltd
NASDAQ:TBLA
|
IL |
Bankruptcy Probability
Mesoblast Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mesoblast Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Mesoblast Ltd
ASX:MSB
|
2.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mesoblast Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mesoblast Ltd has total debt of 66m USD. This includes both short-term (0 USD) and long-term (66m USD) debt.
You can find a full breakdown on its Balance Sheet.
